EmitBio Announces Positive Clinical Results Supporting A Novel Therapeutic for COVID-19

EmitBio™ achieves 99.9% average viral load reduction with faster symptom resolution in adults with COVID-19; submits for Emergency Use Authorization

Durham, N.C. (January 28, 2021) – EmitBio Inc., a life science company using the precise delivery of light to stimulate, protect and heal the body, today announced clinical results from its investigational treatment for adults with mild to moderate COVID-19.